SINGAPORE--(BUSINESS WIRE)--Flashlight Capital Partners Pte. Ltd (“Flashlight Capital”), a meaningful shareholder of KT&G Corporation (KRX: 033780) (“KT&G” or the “Company”), released an official ...

Decentralization, transparency, and anonymity are core mantras in Web3. There is a belief that using hive-thinking produced from members of grassroots communities formed on Twitter and other corners ...

Buying a car is often one of the most expensive purchases people will make next to buying a home. However, for many consumers, the car buying process—from discovering the right vehicle to securing ...

SINGAPORE--(BUSINESS WIRE)--Flashlight Capital Partners Pte. Ltd (“Flashlight Capital”), a shareholder of KT&G Corporation (KRX: 033780) (“KT&G” or the “Company”), released, on its YouTube channel, a ...

Today's podcast looks at the state of venture capital, Airbnb's California pricing display, and corporate travel's move to AI. Good morning from Skift. It’s Friday, June 21, 2024, and here’s what you ...

I maintain my Hold rating on Greenlight Capital Re, due to historically weak reinsurance and long-term investment performance, justifying its valuation discount. Recent $5 million share repurchase at ...

The pharmacy benefits industry is estimated to be worth $550B per annum but it’s filled with complexity and inefficiencies. There’s also no incentive for the incumbent companies to change the model to ...

Car buying has a transparency issue — at least, that’s the way that car buyers perceive it, according to results from the 2022 Capital One Car Buying Outlook. Even as dealers increasingly invest in ...

Rolling out greater price transparency for pharmaceuticals could lead to billions in savings, according to a new analysis. Startup pharmacy benefit manager Capital Rx and 3 Axis Advisors teamed to ...

In recent years, the pharmacy benefits management (PBM) industry's pricing practices have been under intense scrutiny by legislators and the Trump Administration. Today, September 4th, the PBM Capital ...

In the United States, annual prescription drug spend accounts for ~10% of all health spending. Decreases in affordability in prescription drug costs make it more difficult for Americans to secure the ...